The landscape of women's health technology, historically a fragmented and undercapitalised segment of the broader healthcare market, has undergone a fundamental transformation into a sophisticated, multi-vertical ecosystem. As of 2024, the global market reached a significant milestone with a valuation of USD 39.29 billion, but this figure represents only the early stages of a trajectory projected to reach USD 97.25 billion by 2030 and potentially exceed USD 296.85 billion by